Judges Scientific FY adjusted EPS seen ahead of expectations

Scientific instrument business Judges Scientific said on Friday that it now anticipates full-year adjusted earnings per shares will be ahead of market expectations.

Judges stated 2021 was "a year of recovery" for the group from the worst impacts of Covid-19, highlighting that the "adaptability" of its sector and customers, coupled with the reduced severity of lockdowns and university closures, enabled year-on-year organic order intake to increase by 25.1%.

In addition, the AIM-listed firm said despite "remaining commercial challenges" caused by Covid-19, organic order intake was up 8.5% against 2019, which was a record year for the group.

"The group starts 2022 with a strong order book. Organic growth in bookings and a good performance by recently acquired businesses propelled our year-end total order book to 22.5 weeks," said Judges.

"Order intake remains the main driver of performance and consequently, the recovery in orders resulted in good progress in revenues. Organic revenue, which was 5% ahead in the first half, accelerated in the second half to reach double-digits for the year as a whole."

As of 0900 GMT, Judges shares were up 3.79% at 8,490.0p.